Topics
One Theme, Multiple Choices

23 Topics Found
- Journal: 1 Selected
Open for Submission
Advances in Neurorehabilitation
Topic Editors: Nicola Marotta, Antonio Ammendolia, Ennio Lopresti
3 articles | Viewed by 2,135
Deadline: 31 January 2026
Open for Submission
Brain Cancer Stem Cells and Their Microenvironment
Topic Editors: Maria Patrizia Stoppelli, Luca Colucci-D'Amato, Francesca Bianchini
Viewed by 1,162
Deadline: 31 December 2025
Open for Submission
Language: From Hearing to Speech and Writing
Topic Editors: Ana Paula Soares, David Tomé
5 articles | Viewed by 8,898
Deadline: 31 December 2025
Open for Submission
Dysautonomia in Neurological Disorders
Topic Editors: Marco Luigetti, Francesca Vitali
Viewed by 513
Deadline: 20 December 2025
Closed
Management of Multiple Sclerosis: Past, Present and Promise
Topic Editors: Salvatore Iacono, Paolo Ragonese
2 articles | Viewed by 6,056
Deadline: 5 November 2025
Closed
Research Advances in Psychiatric Diseases: Focusing on the Prediction of Suicide
Topic Editors: Maria Skibińska, Monika Wiłkość-Dębczyńska, Przemysław Zakowicz
Viewed by 10,459
Deadline: 15 September 2025
Closed
Translational Advances in Neurodegenerative Dementias
Topic Editors: Francesco Di Lorenzo, Annibale Antonioni
12 articles | Viewed by 40,279
Deadline: 31 October 2024
Closed
Novel Diagnostic and Therapeutic Strategies in Gliomas
Topic Editors: Athanassios P. Kyritsis, George Alexiou
14 articles | Viewed by 58,148
Deadline: 31 December 2023
Closed
Animal Model in Biomedical Research, 2nd Volume
Topic Editors: Marc Ekker, Dong Kwon Yang
19 articles | Viewed by 68,817
Deadline: 31 December 2023
Closed
Bioactive Natural Products and Synthetic Small Molecules as Potential Investigational Treatments for Neurodegenerative Diseases
Topic Editors: Wen-Chi Hou, Wei-Jan Huang, Rita P.-Y. Chen
10 articles | Viewed by 55,870
Deadline: 31 December 2022
Closed
Neuroprotection by Drugs, Nutraceuticals and Physical Activity
Topic Editors: Cristina Angeloni, Andrea Tarozzi
25 articles | Viewed by 128,571
Deadline: 30 September 2022
of 2